Esx5 secretome in TB and TB-HIV pathogenesis and immunity
- Institution
- ALBERT EINSTEIN COLLEGE OF MEDICINE, NY
- Principal investigator
- William Robert Jacobs
- Funding
- $820K
- Duration
- 2025–2030
Moonbase score
Still being scored
Abstract
PROJECT SUMMARY Mycobacterium tuberculosis, the causative agent of human TB, lives exclusively in human cells, and to understand how it causes disease it is important to determine how it delivers its key pathogenic proteins into cells. Using specialized transduction, we generated the only reported complete genetic deletion of the esx5 locus encoding a transport system that is thought to secrete ~150 proteins out of the microbe, and we found that this esx5 mutant is a remarkably good live attenuated vaccine for preventing TB in animal models. In this study we will use our novel esx5 mutant to identify the specific proteins which it secretes, characterize the roles of these secreted proteins in causing disease, and determine the immunologic basis for why the mutant is such a good vaccine.
Research team
- William Ramses BishaiPI
- William Robert JacobsPI
LOADING MOONBASE SCORE
Questions for ALBERT EINSTEIN COLLEGE OF MEDICINE
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Sonoval LlcNot yet scored
Immunotherapy to deplete key Treg subsets in solid tumors
William Ramses Bishai · $706K · 2024–2026
- NIH · Albert Einstein College of MedicineNot yet scored
Generation of a Complete Set of Precise Null Bar-Coded Deletion Mutants of Mycobacterium tuberculosis
William Robert Jacobs · $645K · 2017–2028
- NIH · Albert Einstein College of MedicineNot yet scored
Molecular Genetic Analysis of Mycobacterium Tuberculosis
William Robert Jacobs · $778K · 1988–2028